Company intelligence / Profile preview

GRAS Associates

Holiday, Florida, USA

Ownership: Private
Development stage: Other

Overview

GRAS Associates has submitted approximately 15% of all GRAS notices to FDA since 2008 with a 90% success rate, focusing on regulatory compliance and GRAS submissions, especially for steviol glycosides and other novel ingredients used in foods and supplements[2][3][13][15].

Industry: Consulting

Partnerships

Nutrasource (parent)Daepyung Co., LtdNascent Health SciencesCypress Systems

Beyond the preview

Go deeper on GRAS Associates.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GRAS Associates.

Explore the full profile